title: Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
authors.affiliation: *Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA †Treatment Research Institute, Philadelphia, PA ‡Yale University School of Medicine, New Haven, CT §Oregon Health and Science University, Portland, OR ‖University of California, Los Angeles, Los Angeles, CA ¶University of California, San Francisco, San Francisco, CA #Veterans Affairs Puget Sound Health Care System, Seattle, WA.
authors.forename: George
authors.initials: G
authors.lastname: Woody
authors.forename: Douglas
authors.initials: D
authors.lastname: Bruce
authors.forename: P Todd
authors.initials: PT
authors.lastname: Korthuis
authors.forename: Sumedha
authors.initials: S
authors.lastname: Chhatre
authors.forename: Maureen
authors.initials: M
authors.lastname: Hillhouse
authors.forename: Petra
authors.initials: P
authors.lastname: Jacobs
authors.forename: James
authors.initials: J
authors.lastname: Sorensen
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Saxon
authors.forename: Sabrina
authors.initials: S
authors.lastname: Poole
authors.forename: David
authors.initials: D
authors.lastname: Metzger
authors.forename: Walter
authors.initials: W
authors.lastname: Ling
mesh_terms: D002047:Buprenorphine / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D040242:Risk Reduction Behavior
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine; D008691:Methadone